Concepedia

Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck

Jean‐Pascal Machiels, Marie‐Christine Kaminsky, Ulrich Keller, Tim H. Brümmendorf, Thomas Goddemeier, Ulf Forssmann, Jean‐Pierre Delord

Investigational New Drugs · 2013 · 38 citations · 19 references

DOI

Concepts

References

19

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text

, , +16

Design and Analysis of Phase I Clinical Trials

Barry E. Storer · Biometrics · 1989 · 932 citations

, , +9

Gastrosplenic Fistula From Hodgkin's Lymphoma

Carolyn D. Seib, Flavio G. Rocha, Dick G. Hwang et al. · Journal of Clinical Oncology · 2009 · 736 citations

, , +10

Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Vincent Grégoire, J Lefebvre, Lisa Licitra et al. · Annals of Oncology · 2010 · 617 citations · Full text

, , +11

Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group

Michael K. Gibson, Yi Li, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2005 · 494 citations

, , +14